Abdurahmanova R.F., Izzatov H.N., Hadibaeva G.R., Sharipova B.A., Rashidova O.A., Umarova Z.


Department of Neurology and Medical Genetics of the State educational establishment «Institute of postgraduate education in health sphere of Republic of Tajikistan»

The review considers serious consequences of cerebrovascular diseases — disorders of cognitive functions. In case of chronic insufficiency of cerebral blood supply the cognitive disorders became the main symptom which reflects the severity of vascular lesions of the brain. Most characteristic are the cognitive impairment of «frontal» type. Defects in intellectual-mnestical functions appear. Timely detection of cognitive disorders, before forming of vascular dementia promotes to an earlier conducting of pathogenic therapy what slows down the disorders of informative functions. At the stage of dementia it is expedient to combine neurometabolic drugs with drugs influencing on synthesis of acetylcholine and/or acetylcholinesterase inhibitors.


1.  Bogolepova A. N. Kognitivnye narasheniya u bolnykh s tserebrovaskulyamoy patologiey [Cognitive impairment in pa­tients with cerebrovascular disease]. Lechenie nervnykh bolezney

—      Treatment of nervous diseases, 2011, No. 3, Vol 8, pp. 16-21.

2.  Bogolepova A. N., Gusev E. I. Rol protsessov neyroplas- tichnosti v razvitii depressivnykh rasstroystv [The role of neuro­plasticity processes in the development of depressive disorders]. Trudnyy patsient — The difficult patient, 2010, No. 10, pp. 11-16.

3.  Golubeva V L. Izbrannye lektsii po nevrologii [Selected lectures on neurology]. Moscow, Eydos Media Publ., 2006. 588-621 p.

4.  Gusev E. I., Nikiforov A. S., Gekht A. B. Lekarstvennye sredstva v nevrologicheskoy klinike: rukovodstvo dlya vrachey [Medicines in the neurological clinic: a guide for physicians]. Moscow, MEDpress-inform Publ., 2003. 416 p.

5.  Gusev E. I., Bogolepova A. N. Protsessy neyroplastichno- sti v razvitii depressivnykh rasstroystv [Processes of neuroplas­ticity in development of depressive disorders]. Trudnyy patsient

—      Difficult patient, 2010, No. 10, Vol. 8, pp. 37.

6.   Gusev E. I., Bogolepova A. N. Kognitivnye narusheniya pri tserebrovaskulyarnykh zabolevaniyakh [Cognitive impair­ment in cerebrovascular diseases]. Moscow, MEDpress-inform Publ., 2013. 160 p.

7.  Zakharov V V Kognitivnye narusheniya pri sosudistykh porazheniyakh golovnogo mozga: klinika, diagnostika, lechenie [Cognitive disorders at vascular defeats of the brain: clinic, diagnosis, treatment]. Farmateka-Farmateka, 2009, No. 7.

8.   Zakharov V V., Vakhnina N. V Kognitivnye narusheniya pri tserebrovaskulyarnykh zabolevaniyakh [Cognitive disorders in cerebrovascular diseases]. Rosskiy meditsinskiy zhurnal. Ef- fektivnaya farmakoterapiya — Russian Medical Journal. Effective pharmacotherapy, 2014, No. 1, pp. 36-42.

9.  Zakharov V. V. Sovremennye predstavleniya o khronich- eskoy nedostatochnosti mozgovogo krovoobrashcheniya [Mod­ern conceptions of chronic insufficiency of cerebral circulation]. Rosskiy meditsinskiy zhurnal — Russian Medical Journal, 2014, No. 22, pp. 1-10.

10.  Zakharov V. V. Klinika, diagnostika i lechenie dist- sirkulyatornoy entsefalopatii [Clinic, diagnostics and treatment of discirculatory encephalopathy]. Nevrologiya i psikhiatriya imeni S. S. Korsakova — Neurology and psychiatry named after

S.   S. Korsakov, 2014, No. 16.

11.  Iznak A. F. Neyronalnaya plastichnost i terapiya affek- tivnykh rasstroystv [Neuronal plasticity and therapy affective disorders]. Psikhiatriya i psikhofarmakoterapiya — Psychiatry and psychopharmacotherapy, 2004, No. 2, pp. 3.

12.  Kadykov A. S., Khronicheskie sosudistye zabolevaniya golovnogo mozga: netsirkulyatornaya entsefalopatiya [Chronic vascular diseases of the brain: non circulatory encephalopathy]. Moscow, GEOTAR-Media Publ., 2013. 232 p.

13.  Kadykov A. S., Manvelov A. S., Prakticheskaya nev- rologiya [Practical neurology]. Moscow, GEOTAR-Media Publ.,

2009.    218-230 p.

14.   Kalashnikova L. A Kognitivnye narusheniya i demen- tsiya pri tserebrovaskulyarnykh zabolevaniyakh [Cognitive impairment and dementia in cerebrovascular diseases]. Atmos- fera. Nervnye bolezni — Atmosphere. Nervous Diseases, 2005, No. 2, pp. 36-40.

15.  Levin O. S., Golubeva L. V Kognitivnye rasstroystva [Cognitive disorders]. Meditsinskiy konsilium — Connisilium medicum, 2006, No. 12, pp. 106-110.

16.  Odinak M. M., Sosudistye zabolevaniya golovnogo mozga [Vascular diseases of the brain]. St. Petersburg, Gippokrat Publ., 2003. 160 p.

17.  Parfenov V.A., Starchina Yu.A. Kognitivnye rasstroystva i ikh lechenie u bolnykh arterialnoy gipertenziey [Cognitive dis­orders and their treatment in patients with arterial hypertension]. Russkiy meditsinskiy zhurnal — Russian medical journal, 2007, No. 2, Vol. 15, pp. 117-122.

18.  Parfenov V A., Khasanova D. R. Ishemicheskiy insult [An ischemic stroke]. Moscow, MIA Publ., 2012. 228 p.

19.  Putilina M. V Kognitivnye rasstroystva pri tserebro- vaskulyarnoy patologii [Cognitive disorders in cerebrovascular disease]. Moscow, 2011. 119 p.

20.  Skoromets A. A., Dyakonova M. M. Neyroprotektsiya ostroy i khronicheskoy nedostatochnosti mozgovogo krovoo- brashcheniya [Neuroprotection of acute and chronic insufficiency of cerebral circulation]. St. Peterburg, Nauka Publ., 2007. 200 p.

21.  Starchina Yu. A., Parfenov V A. Kognitivnye rasstroyst­va pri tserebrovaskulyarnykh zabolevaniyakh: diagnoz i lechenie [Cognitive disorders in cerebrovascular diseases: diagnosis and treatment]. Russkiy meditsinskiy zhurnal. Nevrologia — Russian medical journal. Neurology, 2008, No. 12, Vol. 16, pp. 1-3.

22.  Suslina Z. A. Varakin Yu. Ya. Vereshchagin N. V Sosud­istye zabolevaniya golovnogo mozga [Vascular diseases of the brain]. Moscow, MEDpress-inform Publ., 2009. 352 p.

23.  Suslina Z. A., Piradov M. A. Insult: diagnostika, lech­enie, profilaktika [Stroke: diagnosis, treatment, prevention]. Moscow, MEDpress-inform Publ., 2008. 288 p.

24.  Shavlovskaya O. A. Neyroprotektivnaya terapiya pri khronicheskoy ishemii mozga [Neuroprotective therapy in chron­ic brain ischemia]. Rosskiy meditsinskiy zhurnal. Nevrologiya — Russian Medical Journal. Neurology, 2014, No. 3.

25.  Shtok V N. Klinicheskayafarmakologiya vazoaktivnykh sredstv i farmakoterapiya tserebrovaskulyarnykh rasstroystv [Clinical pharmacology of vasoactive drugs and pharmacother­apy of cerebrovascular disorders]. Moscow, MIA Publ., 2009. 584 p.

26.  Shtok V N. Farmakoterapiya v nevrologii [Pharmaco­therapy in neurology]. Moscow, Meditsinskoe informatsionnoe agentstvo Publ., 2010. 536 p.

27.   Shtulman D. R., Levin O. S. Nevrologiya: spravochnik prakticheskogo vracha [Neurology: handbook for the practicing physician]. Moscow, MEDpress-inform Publ., 2004. 864 p.

28.  Yakhno N. N., Zakharov V V., Lokshina A. B., De- mentsii. Rukovodstvo dlya vrachey [Dementia. A manual for physicians]. Moscow, MEDpress-inform Publ., 2010. 272 p.

29.  Barnes D. E., Depressive symptoms, vascular disease, and mild cognitive impairment. Findings from the cardiovascular health study. Archives of General Psychiatry, 2006, Vol. 63, pp. 273-280.

30.  Bernick C., For the Cardiovascular Health Study Collaborative Research Group. Neurology, 2005, Vol. 65, pp. 1388-1394.

31.  Brook J.S., Ghang C., Saar N.S., Brook D.W. Psy­chosocial predictors, higher body mass index, and aspects of neurocognitive dysfunction. Percept Mott Skills, 2009, No. 1, Vol 108, pp. 181-195.

32.   Crook T., Age associated memory impairment: proposed diagnostic criteria and measures of clinical change. Dev. Neuro- psychol, 1986, No. 2, pp. 261 — 76.

33.  Ferri C. P., Prince M. Global prevalence of dementia: a Delphi consensus study. Lancet, 2005, vol. 366, pp. 2112-2117.

34.   Francis P.T., The cholinergic hepothesis ofAlzhheimer’s disease. J. neuro. Neurosurg. Psychiatry, 1999, Vol. 66, pp. 137 — 147.

35.  Jacobsen J.S., Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzhei­mer’s disease. Journal of the American Societyfor Experimental Neuro Therapeutics, 2005, Vol. 2, pp. 612-626.

36.  Modgero P. L., Ferrandez J. Depression in patients with mild cognitive impairment increases the risk of developing de­mentia of Alzheimer type. A prospective cohort study. Archives of Neurology, 2004, Vol. 61, pp. 1290-1293.

37.  Musselman D. L., Marzec U. M., Manatunga A., Platelet reactivity in depressed patients treated with paroxetine: prelim­inary findings. Archives of General Psychiatry, 2000, Vol. 57, pp. 875-882.

38.   Steffens D. C., Bosworth H. B., Subcortical white mat­ter lesions and functional impairment in geriatric depression. Depress Anxiety, 2002, Vol. 15, pp. 23-28.


Back to Top